TCMBANKIN000064 |
diosgenin |
AKOS025402315; MolPort-028-744-580; (25R)-5-Spirosten-3beta-ol; 3beta-Hydroxy-5-spirostene; nitogenin; NSC 226132; Spirost-5-en-3-ol, (3beta,25S)-; diosgenin ; AC-8024; 512-04-9; 22-epi-Yamogenin; C08898; D1634_SIGMA |
C27H42O3 |
414.62 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)O)C)C)C)OC1 |
TCMBANKIN000065 |
dioscin |
LMST01080053; C08897; 3-O-(Rhaa1-4(Rhaa1-2)Glcb)-(25R)-spirost-5-en-3beta-ol; dioscin ; 19057-60-4; Dioscin |
C45H72O16 |
869.04 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)OC9C(C(C(C(O9)C)O)O)O)C)C)C)OC1 |
TCMBANKIN008590 |
dregeoside b |
|
C53H90O22 |
1079.3 g/mol |
CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4(C3CC(C5(C4(CCC5(C(C)O)O)O)C)OC(=O)CC(C)C)O)C)OC)OC6CC(C(C(O6)C)OC7C(C(C(C(O7)C)OC8C(C(C(C(O8)CO)O)O)O)OC)O)OC |
TCMBANKIN008642 |
loureirinc |
|
C16H16O4 |
272.29 g/mol |
COC1=C(C=CC(=C1)O)CCC(=O)C2=CC=C(C=C2)O |
TCMBANKIN009232 |
7,3'-dihydroxy-4'-methoxy-8-methylflavan |
LMPK12020239; AK556082; CHEBI:2244; DTXSID60331807; SCHEMBL17559175; CTK3E9492; 87733-81-1; (2S)-2-(3-hydroxy-4-methoxyphenyl)-8-methyl-3,4-dihydro-2H-1-benzopyran-7-ol; AKOS030531386; (S)-2-(3-Hydroxy-4-methoxyphenyl)-8-methylchroman-7-ol; C09646; (2S)-2-(3-hydroxy-4-methoxy-phenyl)-8-methyl-chroman-7-ol; (2S)-2-(3-hydroxy-4-methoxyphenyl)-8-methyl-3,4-dihydro-2H-chromen-7-ol; AC1L9CO5; 7,3'-Dihydroxy-4'-methoxy-8-methylflavan |
C17H18O4 |
286.32 g/mol |
CC1=C(C=CC2=C1OC(CC2)C3=CC(=C(C=C3)OC)O)O |
TCMBANKIN013940 |
9,12-dihydroxy-15-nonadecenoic acid |
9,12-dihydroxy-15-nonadecenoicacid |
C19H36O4 |
|
CCCC=CCCC(CCC(CCCCCCCC(=O)O)O)O |
TCMBANKIN030541 |
7,4'-dihydroxy-8-methylflavan |
|
C16H16O3 |
256.3 g/mol |
CC1=C(C=CC2=C1OC(CC2)C3=CC=C(C=C3)O)O |
TCMBANKIN032017 |
allylpyrocatechol |
|
C9H10O2 |
150.17 g/mol |
C=CCC1=C(C(=CC=C1)O)O |
TCMBANKIN037880 |
dracorubin |
|
C32H24O5 |
488.5 g/mol |
CC1=C2C3=C(C=C(OC3=CC1=O)C4=CC=CC=C4)C5=C6C(=C(C=C5O2)OC)CCC(O6)C7=CC=CC=C7 |
TCMBANKIN038359 |
draconinc |
|
C40H60O15 |
780.9 g/mol |
CC1C2C(CC3C2(CCC4C3CC=C5C4(C(CC(C5)O)OC6C(C(C(CO6)O)O)OC7C(C(C(C(O7)C)O)O)OC(=O)C)C)C)OC18C(C(C(=C)CO8)O)O |
TCMBANKIN038856 |
draconinb |
|
C42H62O16 |
822.9 g/mol |
CC1C2C(CC3C2(CCC4C3CC=C5C4(C(CC(C5)O)OC6C(C(C(CO6)O)O)OC7C(C(C(C(O7)C)O)OC(=O)C)OC(=O)C)C)C)OC18C(C(C(=C)CO8)O)O |
TCMBANKIN044931 |
(2S)-4',7-Dihydroxy-3'-methoxyflavan |
|
|
|
|
TCMBANKIN046414 |
draconina |
|
C44H64O17 |
865 g/mol |
CC1C2C(CC3C2(CCC4C3CC=C5C4(C(CC(C5)O)OC6C(C(C(CO6)O)O)OC7C(C(C(C(O7)C)OC(=O)C)OC(=O)C)OC(=O)C)C)C)OC18C(C(C(=C)CO8)O)O |
TCMBANKIN058192 |
isoliquiritigenin |
HCC; KBio2_000625; SPBio_000949; Spectrum2_000875; 961-29-5; 2-PROPEN-1-ONE, 1-(2,4-DIHYDROXYPHENYL)-3-(4-HYDROXYPHENYL)-; SPECTRUM1504200; Chalcone, 2',4,4'-trihydroxy-; CHEMBL1395334; KBio3_002631; NCGC00015556-01; SDCCGMLS-0066751.P001; ST5309279; (2E)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one; KBio2_003193; InChI=1/C15H12O4/c16-11-4-1-10(2-5-11)3-8-14(18)13-7-6-12(17)9-15(13)19/h1-9,16-17,19H/b8-3; (E)-1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one; CMLD3_000056; BSPBio_003411; C08650; CCRIS 7676; 2',4,4'-Trihydroxychalcone; Lopac0_000681; 1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one; I159_SIGMA; 1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one; Lopac-I-3766; CPD-3041; KBio1_001802; MEGxp0_001326; ZINC3869607; BRN 1914295; MLS000438943; SMR000112969; Acrylophenone, 2',4'-dihydroxy-3-(p-hydroxyphenyl)-; (2E)-1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one; ACon1_000047; GU 17; KBioGR_002232; DivK1c_006858; KBio2_005761; 1-08-00-00707 (Beilstein Handbook Reference); 4,2′,4′-Trihydroxychalcone; (E)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one; NCGC00090504-01; (Z)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one; EU-0100681; Spectrum3_001656; AC1O7G44; 4,2',4'-Trihydroxychalcone; EINECS 237-316-5; I3766_SIGMA; AIDS035379; AIDS-035379; 13745-20-5; Spectrum5_000612; 2-propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)-, (2E)-; Spectrum_000145; KBioSS_000625; Isoliquiritigenin; Spectrum4_001756; 42'4'-trihydroxychalcone; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)-, (E)-; NCGC00090504-03; SpecPlus_000762; 2',4',4-trihydroxychalcone |
C15H12O4 |
256.25 g/mol |
C1=CC(=CC=C1C=CC(=O)C2=C(C=C(C=C2)O)O)O |
TCMBANKIN058529 |
7-hydroxy-3一(4-hydroxybenzyl)chroman |
7-hydroxy-3-(4-hydroxybenzyl)chromane |
C16H16O3 |
|
C1C(COC2=C1C=CC(=C2)O)CC3=CC=C(C=C3)O |
TCMBANKIN060355 |
methylprotodioscin |
|
C52H86O22 |
1063.23 |
CC1C2C(CC3C2(CCC4C3CC=C5C4(CCC(C5)OC6C(C(C(C(O6)CO)OC7C(C(C(C(O7)C)O)O)O)O)OC8C(C(C(C(O8)C)O)O)O)C)C)OC1(CCC(C)COC9C(C(C(C(O9)CO)O)O)O)OC |
TCMBANKIN060497 |
dioscin |
|
C45H72O16 |
869.04 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)OC9C(C(C(C(O9)C)O)O)O)C)C)C)OC1 |